Setup

In Q1 2026, every Asia-sourced footwear/apparel importer that has filed post-SCOTUS reported the same 250-300bps IEEPA tariff headwind. Four of them gave up margin. One didn't. Wolverine World Wide (WWW, ≈$1.3B market cap) held gross margin flat year-over-year while CROX, COLM, and LEVI compressed. Stock moved +0.85% on the triple beat. The cohort cross-check is in public 10-Qs and not yet synthesized in any single research note.

What the filing says

Q1 2026 (10-Q filed May 14): revenue $457.6M vs guided $445-450M. Gross margin 47.6% — flat YoY, above the ≈47.5% guide. Diluted EPS $0.24 vs guided $0.20-0.22. MD&A language: "Higher tariff costs in the first quarter of 2026 were offset by price increases and by a favorable mix shift toward more full-price sales." The 260bps unmitigated IEEPA tariff was absorbed without margin compression.

Active Group revenue $371.6M (+13.7% YoY). Saucony contributed +$26.1M from EMEA wholesale and international distributor strength; Merrell +$19.1M from the Moab Speed franchise. Work Group $75.7M (+1.2%) — Wolverine brand itself -$1.0M but offset by HYTEST and Harley-Davidson, with Work Group gross margin up 160bps on favorable international mix.

Separately disclosed: ≈$36M of IEEPA tariffs paid before the February 20 Supreme Court ruling. Zero recovery booked under ASC 450 ("not probable"). FY26 guidance not updated for any refund. $135M buyback authorization unused in Q1. Covenants compliant; $492.9M undrawn revolver; ≈90% of debt fixed at 4.0% to August 2029.

What the market thinks

Price $15.35. Forward P/E 8.88x against peer cohort (CROX, COLM, DECK, ONON) at ≈11-13x — an 11-25% multiple discount. Stock did not pop on the triple beat (+0.85% on 1.4x normal volume). Short interest 11.9% with 7-day cover. RSI 28.3, 10% of 52-week range. Six insider open-market purchases since April 29 — CFO Miller +$205K, two directors +$170K each.

The math: at peer 12x × mid-guide EPS $1.43, fair value = $17.16. Current $15.35 implies a $1.81 / $17.16 ≈ 11% discount to peers, which encodes a market-implied P(Q2 GM ≥ 46%) of roughly 35-40%. The same probability, viewed analytically, is closer to 50% given Q1 outperformance and the cohort divergence — implying a ≈10-15% mispricing if the gap closes through earnings.

Why the gap exists

Sell-side covers WWW solo and peers solo. Same-quarter margin divergence — CROX -100bps (10-Q 4/30), COLM -20bps consolidated and US segment -70bps (10-Q 5/7), LEVI Americas -260bps (10-Q 4/9), ONON +430bps but on premium pricing power not comparable mitigation (6-K 5/12), vs WWW 0bps (10-Q 5/14) — is not synthesized in any single research note. The cross-check requires pulling five filings and one foreign 6-K. The public data is unambiguous; the synthesis is absent.

Two real overhangs reinforce the discount: Sweaty Betty impairment risk ($158.5M goodwill + trade name with 16% cushion to fair value) and the 2026 tariff build trajectory (260bps Q1 → 300bps full year). Both are real but separable from the pricing-through question. The IEEPA refund optionality (≈$0.34/share at full recovery) is sector-wide — five disclosed peers carry >$328M aggregate, all unbooked. WWW's $36M is the smallest disclosed amount; it is sector beta, not WWW alpha.

Risks

1. Q2 GM cracks below 45.5% as tariff impact builds Q2-Q4. Pricing-through fails; multiple compresses further.
2. Sweaty Betty impairment — $158.5M at risk, ≈9% of equity. Non-cash but signals portfolio drag.
3. Saucony comp deceleration to HSD as 2025 +30% growth normalizes.
4. Cyclical drawdown amplified by β 1.76.
5. Section 122 worsens or new prospective duties — full-year guide moves down.

Catalysts

• Q2 2026 print, ~August 2026 — primary gate. P(GM ≥ 46%) = 50%.
• Buyback deployment 8-K — $135M at $15 ≈ 8M shares ≈ 10% float reduction.
• IEEPA refund booking — any quarter through FY26 10-K (~Feb 2027). P = 35%.
• Q3 print, ~November 2026 — tariff at peak build.

What would confirm

• Q2 GM ≥ 47% with full-price mix sustained — pricing-through validated as structural, not Q1 fluke.
• Buyback 8-K deploys meaningful portion of $135M at current prices — order-book confirms board view of fair value.
• IEEPA partial recovery booked in any quarter — sector basket rerate, WWW catches the move.
• DECK and VFC post-SCOTUS filings show comparable pricing-through — capability is sector-wide; if not, WWW execution is more idio than thought.

What would break

• Q2 GM < 45.5% — pricing-through fails, thesis dies.
• Sweaty Betty 8-K announcing impairment or strategic review — $158.5M overhang materializes.
• Insider sales above $18 — order-book signal flips.
• Saucony comp deceleration to high-single-digit — engine slowing earlier than guide.
• Section 122 rate worsens or new prospective duties — full-year guide moves down.

Evidence

Memo LR: 1.3 — bullish, market underweighting the cohort margin divergence. Q2 2026 print is the gate.